Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Active surveillance: oncologic outcome.
Venderbos LD, Bokhorst LP, Bangma CH, Roobol MJ. Venderbos LD, et al. Among authors: bokhorst lp. Curr Opin Urol. 2013 May;23(3):268-72. doi: 10.1097/MOU.0b013e32835efe8f. Curr Opin Urol. 2013. PMID: 23425994 Review.
Reply from authors re: Michael Baum. Screening for prostate cancer: can we learn from the mistakes of the breast screening experience? Eur Urol 2013;64:540-1: screening for prostate cancer: we have learned and are still learning.
Roobol MJ, Kranse R, Bangma CH, Otto SJ, van der Kwast TH, Bokhorst LP, de Koning HJ, Schröder FH. Roobol MJ, et al. Among authors: bokhorst lp. Eur Urol. 2013 Oct;64(4):541-3. doi: 10.1016/j.eururo.2013.06.033. Epub 2013 Jun 26. Eur Urol. 2013. PMID: 23816273 No abstract available.
Prostate-specific antigen-based prostate cancer screening: reduction of prostate cancer mortality after correction for nonattendance and contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
Bokhorst LP, Bangma CH, van Leenders GJ, Lous JJ, Moss SM, Schröder FH, Roobol MJ. Bokhorst LP, et al. Eur Urol. 2014 Feb;65(2):329-36. doi: 10.1016/j.eururo.2013.08.005. Epub 2013 Aug 11. Eur Urol. 2014. PMID: 23954085 Clinical Trial.
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Määttänen L, Lilja H, Denis LJ, Recker F, Paez A, Bangma CH, Carlsson S, Puliti D, Villers A, Rebillard X, Hakama M, Stenman UH, Kujala P, Taari K, Aus G, Huber A, van der Kwast TH, van Schaik RH, de Koning HJ, Moss SM, Auvinen A; ERSPC Investigators. Schröder FH, et al. Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6. Lancet. 2014. PMID: 25108889 Free PMC article. Clinical Trial.
The ProtecT trial: what can we expect?
Roobol MJ, Bokhorst LP. Roobol MJ, et al. Among authors: bokhorst lp. Lancet Oncol. 2014 Sep;15(10):1046-7. doi: 10.1016/S1470-2045(14)70198-6. Epub 2014 Aug 19. Lancet Oncol. 2014. PMID: 25163904 Free article. No abstract available.
29 results